Recent Updates
Recently added Catalysts
ATEC Positive Sentiment

ATEC Announces Participation in Upcoming Investor Conferences

Monday, July 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Alphatec Holdings, Inc. (ATEC) has announced its participation in upcoming investor conferences. The company will host one-on-one meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and will present at the 19th Annual Piper Sandler MedTech conference. This engagement reflects ATEC's commitment to investor relations.
Price reaction · baseline $8.67 (2026-07-27 close) · hit after-hours · clean, no other ATEC news in the window
day 0 close
+7.5%
day 1 · peak
+11.3%
day 3
+9.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • ATEC is actively engaging with investors.
  • Participation in notable investor conferences.
  • Opportunity for one-on-one meetings enhances investor relations.

Full Press Release Details

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 10, 2026. Management will present to investors at the 19th Annual Piper Sandler MedTech and Dia

Frequently Asked Questions

What conferences will ATEC participate in?

ATEC will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference and the 19th Annual Piper Sandler MedTech conference.

When is the Needham Virtual MedTech Conference?

The Needham Virtual MedTech & Diagnostics 1x1 Conference is scheduled for August 10, 2026.

What type of meetings will ATEC host?

ATEC will host one-on-one investor meetings during the conferences.

ShareAdd on Google
Tags: ATEC Viatris Investor Conferences Healthcare Alphatec Holdings investor conferences MedTech Piper Sandler
Last updated: Jul 27, 2026

Biotech snapshot

Cash runway
$119M liquidity · $0M/mo burn
Low dilution risk